Your browser doesn't support javascript.
loading
Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study.
Russo, Vincenzo; Caturano, Alfredo; Guerra, Federico; Migliore, Federico; Mascia, Giuseppe; Rossi, Andrea; Nesti, Martina; Santobuono, Vincenzo Ezio; Attena, Emilio; Tola, Gianfranco; Sciarra, Luigi; Conte, Giulio; Paoletti Perini, Alessandro; Francia, Pietro; Dendramis, Gregory; Palamà, Zefferino; Albani, Stefano; Ottonelli Ghidini, Andrea; Calò, Leonardo; D'Onofrio, Antonio; Baldi, Enrico.
Afiliación
  • Russo V; Department of Medical Translational Sciences, Division of Cardiology, University of Campania "Luigi Vanvitelli", Monaldi Hospital, Naples, Italy. v.p.russo@libero.it.
  • Caturano A; Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Piazza Luigi Miraglia 2, T80138, Naples, Italy.
  • Guerra F; Azienda Ospedaliera Universitaria Ospedali Riuniti, Ancona, Italy.
  • Migliore F; Università degli Studi di Padova, Padua, Italy.
  • Mascia G; IRCCS San Martino Polyclinic Hospital, Genoa, Italy.
  • Rossi A; Gabriele Monasterio Foundation, Pisa, Italy.
  • Nesti M; Cardiovascular and Neurological Department, Ospedale San Donato, Via Nenni, 20/22, 52100, Arezzo, Italy.
  • Santobuono VE; Department of Interdisciplinary Medicine and Policlinico of Bari, Cardiology Unit, University of Bari "Aldo Moro", Bari, Italy.
  • Attena E; Cardiology Unit, Roccadaspide Hospital, ASL Salerno, Roccadaspide, Italy.
  • Tola G; Azienda Ospedaliera Brotzu, Cagliari, Italy.
  • Sciarra L; Policlinico Casilino, Cardiology Unit, Rome, Italy.
  • Conte G; Cardiocentro Ticino Foundation, Lugano, Switzerland.
  • Paoletti Perini A; Azienda Sanitaria di Firenze, Florence, Italy.
  • Francia P; Azienda Ospedaliero-Universitaria Sant'Andrea, Rome, Italy.
  • Dendramis G; Clinical and Interventional Arrhythmology, Cardiology Unit, ARNAS, Ospedale Civico Di Cristina Benfratelli, Palermo, Italy.
  • Palamà Z; Casa di Cura Villa Verde, Taranto, Italy.
  • Albani S; Umberto Parini Regional Hospital, Aosta, Italy.
  • Ottonelli Ghidini A; Versilia Hospital, Cardiology Unit, Lido di Camaiore (LU), Italy.
  • Calò L; Policlinico Casilino, Cardiology Unit, Rome, Italy.
  • D'Onofrio A; Departmental Unit of Electrophysiology, Evaluation and Treatment of Arrhythmias, Monaldi Hospital, Naples, Italy.
  • Baldi E; IRCCS Policlinico San Matteo, Pavia, Italy.
Heart Vessels ; 38(5): 680-688, 2023 May.
Article en En | MEDLINE | ID: mdl-36418560
No real-world data are available about the complications rate in drug-induced type 1 Brugada Syndrome (BrS) patients with an implantable cardioverter-defibrillator (ICD). Aim of our study is to compare the device-related complications, infections, and inappropriate therapies among drug-induced type 1 BrS patients with transvenous- ICD (TV-ICD) versus subcutaneous-ICD (S-ICD). Data for this study were sourced from the IBRYD (Italian BRugada sYnDrome) registry which includes 619 drug-induced type-1 BrS patients followed at 20 Italian tertiary referral hospitals. For the present analysis, we selected 258 consecutive BrS patients implanted with ICD. 198 patients (76.7%) received a TV-ICD, while 60 a S-ICD (23.4%). And were followed-up for a median time of 84.3 [46.5-147] months. ICD inappropriate therapies were experienced by 16 patients (6.2%). 14 patients (7.1%) in the TVICD group and 2 patients (3.3%) in S-ICD group (log-rank P = 0.64). ICD-related complications occurred in 31 patients (12%); 29 (14.6%) in TV-ICD group and 2 (3.3%) in S-ICD group (log-rank P = 0.41). ICD-related infections occurred in 10 patients (3.88%); 9 (4.5%) in TV-ICD group and 1 (1.8%) in S-ICD group (log-rank P = 0.80). After balancing for potential confounders using the propensity score matching technique, no differences were found in terms of clinical outcomes between the two groups. In a real-world setting of drug-induced type-1 BrS patients with ICD, no significant differences in inappropriate ICD therapies, device-related complications, and infections were shown among S-ICD vs TV-ICD. However, a reduction in lead-related complications was observed in the S-ICD group. In conclusion, our evidence suggests that S-ICD is at least non-inferior to TV-ICD in this population and may also reduce the risk of lead-related complications which can expose the patients to the necessity of lead extractions.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Desfibriladores Implantables / Síndrome de Brugada Límite: Humans Idioma: En Revista: Heart Vessels Asunto de la revista: CARDIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Desfibriladores Implantables / Síndrome de Brugada Límite: Humans Idioma: En Revista: Heart Vessels Asunto de la revista: CARDIOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Italia